Back to Agenda
Session 5: Facilitating Access to Innovation in Asia / Practical pragmatic approaches
Session Chair(s)
Thean Soo Lo
Regulatory Affairs Management Consultant, TS Consulting, Singapore
Audrey Ooi, MSC
Head- Business Development, Clinical Research Malaysia, Malaysia
Speaker(s)
Angelika Joos, MPHARM
Executive Director, Science & Regulatory Policy, MSD, Belgium
Facilitating Regulatory Collaboration to Speed up Patient Access - Industry Perspective
Wittawat Viriyabancha
Pharmacist Professional Level, Pre-Marketing Control Division,, Thai Food and Drug Administration, Thailand
Support for Innovation and Accelerated access
Lesley Maloney, PHARMD
Regulatory Policy Lead, Genentech, A Member of the Roche Group, United States
Re-imaging the Regulatory Paradigm for Digital Health
Mari Shirotani, PHD
Office Director, Office of Advanced Evaluation with Electronic Data, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
PMDA’s Activities to Promote Rapid Patient Access
Cynthia Sung Ang, MPH, RPH
Regulatory Consultant, Health Sciences Authority, Singapore
Data Analytics for Active Surveillance
Nicholas Leow Chun Wei
Head of Section GCP, NPRA, Malaysia
Phase I Unit Accreditation for FIH Studies in Malaysia
Have an account?